Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-2791
Education & Training
University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2013 - 2016
Albert Einstein Medical CenterInternship, Transitional Year, 2012 - 2013
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
PA State Medical License 2012 - 2024- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Roles: Contact
Publications & Presentations
PubMed
- INCIDENCE AND RISK FACTORS FOR EXUDATIVE RETINAL DETACHMENT FOLLOWING LASER PHOTOCOAGULATION FOR RETINOPATHY OF PREMATURITY.Devin Cohen, Gil Binenbaum, Khalid El-Jack, Alyssa Spiller, Yinxi Yu
Retina. 2024-02-01 - 1 citationsAutism Spectrum Disorder in Pediatric Idiopathic Intracranial HypertensionAnne K. Jensen, Claire A. Sheldon, Grace L. Paley, Christina L. Szperka, Geraldine Liu
Life. 2021-09-15 - 2 citationsSymmetry of Disease in Retinopathy of Prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.Lisa Y. Lin, Anne K. Jensen, Graham E. Quinn, Alyssa Spiller, Lauren A. Tomlinson
Ophthalmic Epidemiology. 2020-06-11
Press Mentions
Mike Dannheim, Co-Founder of Sensie – How Technology Can Help to Detect Stress and Offer Real Solutions to Eliminate ItSeptember 10th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
